- Transaction broadens and builds upon UCB's role as a leader in, and our continued commitment to, addressing unmet needs of people living with epilepsy, complementing existing medicines and
Quantification may help stratify SUDEP risk People who died due to sudden unexpected death in epilepsy (SUDEP) had changes in frequency-domain measures of heart rate variability compared with living epilepsy controls, a retrospective, nested case-control study found. Compared with non-SUDEP epilepsy controls, epilepsy patients who died with SUDEP had lower normalized awake low-frequency power (LFP)
Novartis has lost another NIBR exec to the call of biotech. Blueprint Medicines has added another BMS vet to its roster. And Iovance quietly announced its CEO's departure Wednesday.
Zogenix Launches Global Access Program for FINTEPLA® (Fenfluramine) Oral Solution pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.